Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients.
García-López M, Lens S, Pallett LJ, Testoni B, Rodríguez-Tajes S, Mariño Z, Bartres C, García-Pras E, Leonel T, Perpiñán E, Lozano JJ, Rodríguez-Frías F, Koutsoudakis G, Zoulim F, Maini MK, Forns X, Pérez-Del-Pulgar S. García-López M, et al. Among authors: koutsoudakis g. J Hepatol. 2021 May;74(5):1064-1074. doi: 10.1016/j.jhep.2020.11.043. Epub 2020 Dec 2. J Hepatol. 2021. PMID: 33278456 Free PMC article.
Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8+ T cells after direct-acting antiviral therapies.
Perpiñán E, Pérez-Del-Pulgar S, Londoño MC, Mariño Z, Lens S, Leonel T, Bartres C, García-López M, Rodriguez-Tajes S, Forns X, Koutsoudakis G. Perpiñán E, et al. Among authors: koutsoudakis g. J Viral Hepat. 2020 Dec;27(12):1408-1418. doi: 10.1111/jvh.13370. Epub 2020 Aug 18. J Viral Hepat. 2020. PMID: 32812325
Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free Therapy.
Perpiñán E, Pérez-Del-Pulgar S, Londoño MC, Mariño Z, Bartres C, González P, García-López M, Pose E, Lens S, Maini MK, Forns X, Koutsoudakis G. Perpiñán E, et al. Among authors: koutsoudakis g. Front Immunol. 2020 Feb 25;11:129. doi: 10.3389/fimmu.2020.00129. eCollection 2020. Front Immunol. 2020. PMID: 32161581 Free PMC article.
Hepatitis C virus intrinsic molecular determinants may contribute to the development of cholestatic hepatitis after liver transplantation.
Gambato M, Gregori J, Quer J, Koutsoudakis G, González P, Caro-Pérez N, García-Cehic D, García-González N, González-Candelas F, Esteban JI, Crespo G, Navasa M, Forns X, Pérez-Del-Pulgar S. Gambato M, et al. Among authors: koutsoudakis g. J Gen Virol. 2019 Jan;100(1):63-68. doi: 10.1099/jgv.0.001175. Epub 2018 Nov 19. J Gen Virol. 2019. PMID: 30451649
Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antivirals.
Perpiñán E, Caro-Pérez N, García-González N, Gregori J, González P, Bartres C, Soria ME, Perales C, Lens S, Mariño Z, Londoño MC, Ariza X, Koutsoudakis G, Quer J, González-Candelas F, Forns X, Pérez-Del-Pulgar S. Perpiñán E, et al. Among authors: koutsoudakis g. J Viral Hepat. 2018 Dec;25(12):1515-1525. doi: 10.1111/jvh.12986. Epub 2018 Oct 4. J Viral Hepat. 2018. PMID: 30141252
Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo.
Koutsoudakis G, Paris de León A, Herrera C, Dorner M, Pérez-Vilaró G, Lyonnais S, Grijalvo S, Eritja R, Meyerhans A, Mirambeau G, Díez J. Koutsoudakis G, et al. Antimicrob Agents Chemother. 2017 Apr 24;61(5):e02354-16. doi: 10.1128/AAC.02354-16. Print 2017 May. Antimicrob Agents Chemother. 2017. PMID: 28193659 Free PMC article.
33 results